Biotech Stocks on the Upswing as Favorable Legislation Boosts Investor OptimismFont size: A | A | A8:21 AM ET 3/19/12 | Marketwire RELATED QUOTES
3:59 PM ET 3/16/12 Symbol Last % Chg CLSN 1.69 0.00% MNKD 2.33 0.00% Quotes delayed at least 15 minutes
Biotechnology stocks continue to be some of the strongest performers in the markets as favorable legislation out of Washington boosts the sector's reach. The iShares NASDAQ Biotechnology Index (IBB) is currently up more than 16 percent year to date, reflecting an uptick in investor sentiment. Earlier this month the Biotechnology Industry Organization applauded the Faster Access to Specialized Treatments (FAST) Act. According to BIO the legislation will modernize the Accelerated Approval pathway to expedite the development of modern, targeted, and personalized therapies for patients suffering from serious and life-threatening diseases.
BIO President and CEO Jim Greenwood says the FAST act will speed access to innovative new therapies and cures to patients living with debilitating and life-threatening diseases such as Parkinson's, Alzheimer's, diabetes and numerous rare diseases for which there is currently no treatment or cure.
SOURCE: Paragon Financial Limited
PYC Price at posting:
4.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)